Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus

Brain Research

Volumn 1262, Issue , 2009, Pages 64-72

  Falenski, Katherine W ^a   Carter, Dawn S ^a   Harrison, Anne J ^b   Martin, Billy R ^b   Blair, Robert E ^a   DeLorenzo, Robert J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Epileptogenesis; Immunohistochemistry; Plasticity; Redistribution; Time course

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTATE GYRUS; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; NERVE CELL PLASTICITY; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEIZURE; STRATUM ORIENS; STRATUM PYRAMIDALE; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DENTATE GYRUS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERNEURONS; MALE; MUSCARINIC AGONISTS; PILOCARPINE; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SEIZURES; STATUS EPILEPTICUS; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 61849166674     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.036     Document Type: Article

References (40)

1. Andre V., et al. Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11 (2001) 452-468
2. Blair R.E., et al. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J. Pharmacol. Exp. Ther. 317 (2006) 1072-1078
3. Boulland J.L., et al. Changes in vesicular transporters for gamma-aminobutyric acid and glutamate reveal vulnerability and reorganization of hippocampal neurons following pilocarpine-induced seizures. J. Comp. Neurol. 503 (2007) 466-485
4. Chen K., et al. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39 (2003) 599-611
5. Chen K., et al. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 27 (2007) 46-58
6. Clement A.B., et al. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J. Neurosci. 23 (2003) 3916-3923
7. Coomber B., et al. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid. Synapse 62 (2008) 746-755
8. Covolan L., and Mello L.E. Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res. 39 (2000) 133-152
9. Dinocourt C., et al. Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures. J. Comp. Neurol. 459 (2003) 407-425
10. Falenski K.W., et al. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146 (2007) 1232-1244
11. Hajos N., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12 (2000) 3239-3249
12. Hauser H. Epilepsy: Frequency, Causes and Consequences, vol. (1990), Demos, New York
13. Katona I., et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19 (1999) 4544-4558
14. Katona I., et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006) 5628-5637
15. Kawamura Y., et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26 (2006) 2991-3001
16. Kobayashi M., and Buckmaster P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci. 23 (2003) 2440-2452
17. Leite J.P., et al. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci. Biobehav. Rev. 14 (1990) 511-517
18. Ludanyi A., et al. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 28 (2008) 2976-2990
19. Mailleux P., and Vanderhaeghen J.J. Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen. Eur. J. Pharmacol. 266 (1994) 193-196
20. Marsicano G., and Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11 (1999) 4213-4225
21. Marsicano G., et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
22. McDonald A.J., and Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 107 (2001) 641-652
23. Mello L.E., et al. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34 (1993) 985-995
24. Monory K., et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 (2006) 455-466
25. Monory K., et al. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol. 5 (2007) e269
26. Morimoto K., et al. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73 (2004) 1-60
27. Morris T.A., et al. Chronic DeltaFosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy. Brain Res. Mol. Brain Res. 79 (2000) 138-149
28. Naderi N., et al. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J. Neural. Transm. 115 11 (2008) 1501-1511 (Nov)
29. Ohno-Shosaku T., et al. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. J. Physiol. 584 (2007) 407-418
30. Paxinos W. The Rat Brain in Stereotaxic Coordinates, vol. (1986), Academic Press, San Diego
31. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
32. Raza M., et al. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17522-17527
33. Rice A.C., and DeLorenzo R.J. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782 (1998) 240-247
34. Stella N., et al. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
35. Tsou K., et al. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
36. Tsou K., et al. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93 (1999) 969-975
37. Wallace M.J., et al. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur. J. Pharmacol. 428 (2001) 51-57
38. Wallace M.J., et al. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452 (2002) 295-301
39. Wallace M.J., et al. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 307 (2003) 129-137
40. Weise J., et al. Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: contribution of delayed neuronal cell death to seizure-induced neuronal injury. Neurobiol. Dis. 18 (2005) 582-590